Split History
ETFs Holding PLX »    PLX Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Protalix BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company. Co.'s proprietary ProCellEx platform is being used to manufacture its marketed product, Elelyso®, for the treatment of Gaucher disease. Co. is also developing, via ProCellEx, a pipeline of products and are in clinical phase development with pegunigalsidase alfa, or PRX-102, for the treatment of Fabry disease; tulinercept, or OPRX-106, for the treatment of Inflammatory Bowel Diseases; product alidornase alfa, or PRX-110, for the treatment of various indications; and Uricase, or PRX-115, for the treatment of Gout. Co. has other product candidates in early and preclinical development. According to our PLX split history records, Protalix BioTherapeutics has had 3 splits.
PLX split history picture
Protalix BioTherapeutics (PLX) has 3 splits in our PLX split history database. The first split for PLX took place on December 05, 1991. This was a 4 for 3 split, meaning for each 3 shares of PLX owned pre-split, the shareholder now owned 4 shares. For example, a 1000 share position pre-split, became a 1333.33333333333 share position following the split. PLX's second split took place on August 14, 1992. This was a 3 for 2 split, meaning for each 2 shares of PLX owned pre-split, the shareholder now owned 3 shares. For example, a 1333.33333333333 share position pre-split, became a 2000 share position following the split. PLX's third split took place on December 20, 2019. This was a 1 for 10 reverse split, meaning for each 10 shares of PLX owned pre-split, the shareholder now owned 1 share. For example, a 2000 share position pre-split, became a 200 share position following the split.

When a company such as Protalix BioTherapeutics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as Protalix BioTherapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the PLX split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Protalix BioTherapeutics shares, starting with a $10,000 purchase of PLX, presented on a split-history-adjusted basis factoring in the complete PLX split history. PLX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/21/2011
End date: 06/18/2021
Start price/share: $62.90
End price/share: $2.00
Dividends collected/share: $0.00
Total return: -96.82%
Average Annual Total Return: -29.17%
Starting investment: $10,000.00
Ending investment: $317.81
Years: 10.00
Date Ratio
12/05/19914 for 3
08/14/19923 for 2
12/20/20191 for 10
PLX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

PLXP Split History
PMD Split History
PPHM Split History
PRAN Split History
PRGO Split History
PRPO Split History
PRSN Split History
PRTK Split History
PRXL Split History
PSTI Split History

BetaPro NASDAQ-100 2x Daily Bull ETF (HQU)
BetaPro S&P 500 2x Daily Bull ETF (HSU)
BetaPro S&P/TSX Capped Energy 2x Daily Bull ETF (HEU)
BetaPro S&P/TSX Capped Financials 2x Daily Bull ETF (HFU)
BetaPro S&P/TSX 60 2x Daily Bull ETF (HXU)
BetaPro Crude Oil Leveraged Daily Bull ETF (HOU)
Horizons Big Data & Hardware Index ETF (HBGD.U)
Horizons Big Data & Hardware Index ETF (HBGD)
Horizons NASDAQ-100 Index ETF (HXQ.U)
Horizons NASDAQ-100 Index ETF (HXQ)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PLX Insider Buying

PLX Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.